EUVIMEDEUVIMED entdecken
Crossref

L26/P-642 The role of Whole Exome Sequencing (WES) in predicting PGT-M in high-consanguinity populations

V. Ferracuti, I. Elkhatib, R. Gonzales, H. Didar, A. Bayram, A. Abdala, N. Hourani, S. Siqueira, R. Del Gallego, H. Fatemi, D. Nogueira

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.972 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von V. Ferracuti und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question What proportion of couples undergoing Whole Exome Sequencing (WES), stratified by couple characteristics, ultimately require PGT-M? Summary answer Couple consanguinity markedly increases WES positivity and independently predicts PGT-M indication, supporting its use as a key genetic risk stratification factor in IVF care. What is known already About 20% of the world population live in communities where consanguineous marriage is culturally preferred, hence whole exome sequencing (WES) is increasingly integrated into reproductive medicine to identify pathogenic variants and guide preimplantation genetic testing for monogenic disorders (PGT-M). Its clinical utility is expected to be higher in populations with elevated consanguinity rates, where autosomal recessive disorders are more prevalent. However, robust epidemiological data quantifying WES diagnostic yield and subsequent PGT-M indication according to different consanguinity measures are scarce, particularly in IVF populations characterized by high consanguinity. Study design, size, duration A retrospective cohort study including 2,356 IVF patients with definitive WES results treated at a tertiary referral IVF center between March 2020 and September 2025. Participants/materials, setting, methods Couples undergoing IVF with WES followed by PGT-A and/or PGT-M were included. Consanguinity was classified as couple, female parental, or male parental (close, far, none). Associations with WES positivity were evaluated using descriptive analyses and multivariable penalized logistic regression. Main results and the role of chance Overall, 20.4% patients had WES-positive result, showing a strong gradient according to couple consanguinity: 10.0% in non-consanguineous couples, 27.7% in far-related couples, and 36.7% in close-related couples (P < 0.001). In multivariable analysis, close couple consanguinity was the strongest independent predictor of WES positivity (adjusted OR 7.35, [5.51–9.79]), followed by far couple consanguinity (aOR 4.25 [2.87–6.30]). Female, but not male, parental consanguinity showed a modest independent association. Previous affected child was also strongly associated with WES positivity (aOR 18.43, 95% CI 9.79–34.70), whereas recurrent miscarriage and recurrent implantation failure were not. Among WES-positive couples undergoing PGT-M, close consanguinity was associated with testing of a higher number of genes. Overall, 189 (68.0%) had 1 gene tested, 66 (23.7%) had 2 genes, and 23 (8.3%) had ≥3 genes. The number of genes tested in derived embryos differed by couple consanguinity (P = 0.028), with a tendency toward higher gene counts among close couple consanguinity (median 1 [IQR 1–2]) compared with no or far consanguinity (both median 1 [IQR 1–1]). In an ordinal regression model including all three consanguinity measures, close couple consanguinity was associated with higher gene-testing category (adjusted shift OR ≈ 2.05, P = 0.041). Limitations, reasons for caution The retrospective single-center design may limit generalizability. Variant interpretation may also be influenced by population-specific underrepresentation in reference databases. Wider implications of the findings Couple consanguinity should be prioritized in pre-WES counseling and IVF planning to optimize PGT-M use and genetic resource allocation in high-consanguinity regions. Incorporating population structure into reproductive guidelines improves WES diagnostic yield estimates, while the 10.0% positivity rate in non-consanguineous couples underscores the broader clinical relevance of WES. Trial registration number No

Zitieren

APA

Ferracuti, V., Elkhatib, I., Gonzales, R., Didar, H., Bayram, A., Abdala, A., Hourani, N., Siqueira, S., Gallego, R. D., Fatemi, H., & Nogueira, D. (2026). L26/P-642 The role of Whole Exome Sequencing (WES) in predicting PGT-M in high-consanguinity populations. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.972

Vancouver

Ferracuti V, Elkhatib I, Gonzales R, Didar H, Bayram A, Abdala A, et al. L26/P-642 The role of Whole Exome Sequencing (WES) in predicting PGT-M in high-consanguinity populations. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.972

BibTeX
@article{Ferracuti2026,
  author = {Ferracuti, V. and Elkhatib, I. and Gonzales, R. and Didar, H. and Bayram, A. and Abdala, A. and Hourani, N. and Siqueira, S. and Gallego, R. Del and Fatemi, H. and Nogueira, D.},
  title = {L26/P-642 The role of Whole Exome Sequencing (WES) in predicting PGT-M in high-consanguinity populations},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.972}
}
Kostenlos starten →